Amy Surkis

Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera’s bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.

Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.